Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 2010

G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068879 Adalimumab A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. Adalimumab-adbm,Adalimumab-atto,Amjevita,Cyltezo,D2E7 Antibody,Humira,Antibody, D2E7
D000069285 Infliximab A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE. Inflectra,Infliximab-abda,Infliximab-dyyb,MAb cA2,Monoclonal Antibody cA2,Remicade,Renflexis,Antibody cA2, Monoclonal,Infliximab abda,Infliximab dyyb,cA2, Monoclonal Antibody
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D001004 Anus Diseases Diseases involving the ANUS. Anus Disease,Disease, Anus,Diseases, Anus
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
April 2017, Intestinal research,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
August 2020, Medical science monitor : international medical journal of experimental and clinical research,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
July 2014, Alimentary pharmacology & therapeutics,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
December 2011, Techniques in coloproctology,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
November 2008, Alimentary pharmacology & therapeutics,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
January 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
December 2010, Journal of Crohn's & colitis,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
August 2012, Diseases of the colon and rectum,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
October 2004, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland,
G Poggioli, and S Laureti, and F Pierangeli, and P Bazzi, and M Coscia, and L Gentilini, and P Gionchetti, and F Rizzello
October 2023, Digestive diseases and sciences,
Copied contents to your clipboard!